Category: News

Home News
Post

‘Peddi’ BO day 9: Ram Charan film earns Rs 286.38 cr

Ram Charan’s sports action drama ‘Peddi’ continued its theatrical run on Day 9, though the film witnessed another decline in collections.According to Sacnilk, ‘Peddi’ collected Rs 5.15 crore net in India on its ninth day. The figure marks an 18.3 percent drop from the Rs 6.30 crore net collection recorded on Day 8. India collections...

Post

Bangladesh border guards raise pushback issue at BSF meet

File photo NEW DELHI: The Border Guard Bangladesh (BGB), during the Director General-level talks with BSF here that concluded Thursday, raised the alleged pushback of Bangladeshi illegal immigrants into its side of the border, complaining that the legal and diplomatic protocols were not being followed. However the BSF drew BGB’s attention to the nearly 3,000...

Post

Rebels claim 19 MPs in ‘real TMC’ fight, set to meet Speaker

Rebels claim 19 MPs in ‘real TMC’ fight, set to meet Speaker NEW DELHI/KOLKATA: Rebel TMC LS members plan to meet Speaker Om Birla Monday to seek recognition as the “real TMC” parliamentary group, dissident Cooch Behar MP Jagadish Chandra Basunia said Friday, prompting strong reactions from the faction led by party chief Mamata Banerjee.“The...

Post

‘No writs after polls begin’: Supreme Court rejects Meenakshi Natarajan’s plea

Supreme Court to hear Congress leader Meenakshi Natarajan’s writ on RS nomination rejection NEW DELHI: Supreme Court Friday dismissed Congress candidate Meenakshi Natarajan’s petition challenging rejection of her nomination for Rajya Sabha elections from Madhya Pradesh, refusing to carve out an exception from the judicially well-settled principle that bars courts from entertaining election disputes after...

Post

Price cap on 2 key cancer drugs increased by 50%

Representative image NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating raw material costs and supply concerns.The regulator has also revised prices of anti-tetanus immunoglobulin and three key childhood vaccines to ensure their continued...

× Free India Logo
Welcome! Free India